Raphaël Wisniewski

Raphaël began his career in London, where he spent seven years in the healthcare and investment banking industries. He was first part of the finance department of Générale de Santé International in London, the largest private hospitals group in the UK, where he held treasury and investment analysis functions. He subsequently worked in the healthcare groups of the Investment Banking divisions of Salomon Smith Barney (1996-1999) and Goldman Sachs (1999-2001) where he participated in many M&A and capital raising deals within pharmaceuticals, medical devices, biotechnology and services companies. Since joining EdRIP in 2001 he has worked on several investments, IPOs and trade sales in the biotechnology and medical device sectors. He currently sits on the boards of Cellnovo Group, Poxel, Genticel, Implanet, Chase Pharmaceuticals and Axonics.